Specifically, Fan et al. demonstrated an innovative Metal-Organic Framework (MOF) nanosystem in treating osteosarcoma, offering concurrent chemo-immunotherapy and targeting MDSCs alongside modifying IDO activity, thereby substantially reducing tumor progression through a focus on the critical function of MDSCs (Fan et al., 2022). The gene discussed is IDO1; the disease is neoplasm.